Counterfeiting, Compliance, and Controls

FDA and manufacturers seek to curb drug counterfeiting while legislators consider liberalizing drug importing policies to cut pharmaceutical costs.

Related Content:

Regulatory WatchSupply ChainAnticounterfeiting, Track and Trace SystemsPharmaceutical Technology-09-02-2003

Sustainable Shippers for Ultra-Cold Conditions

Major Challenges Ahead for FDA and Pharma

60 Million Doses of the COVID-19 Vaccine is Added to Moderna’s Supply Agreement with the UK